DCF — TEXAS ORTHOPEDIC HOSPITA
Enterprise Value: $151.6M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$151.6M
Enterprise Value
$38.6M
PV of Cash Flows
$113.0M
PV of Terminal Value
$182.0M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $245.0M | $20.8M | 8.0% | $6.8M | $6.2M |
| Year 2 | $252.3M | $24.0M | 9.0% | $8.9M | $7.3M |
| Year 3 | $259.9M | $27.3M | 10.0% | $11.1M | $8.3M |
| Year 4 | $267.7M | $29.4M | 11.0% | $12.4M | $8.5M |
| Year 5 | $275.7M | $31.0M | 11.0% | $13.3M | $8.3M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $151.6M. Terminal value accounts for 75% of total EV — typical range (60-80%).
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$237.8M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base0.07999999966364922
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5